Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2002 Feb;110(Suppl 1):119–128. doi: 10.1289/ehp.02110s1119

Perspectives on the chemical etiology of breast cancer.

Lillian S DeBruin 1, P David Josephy 1
PMCID: PMC1241154  PMID: 11834470

Abstract

Multiple factors, known and unknown, contribute to human breast cancer. Hereditary, hormonal, and reproductive factors are associated with risk of breast cancer. Environmental agents, including chemical carcinogens, are modifiable risk factors to which over 70% of breast cancers have been attributed. Polymorphisms of drug-metabolizing enzymes may influence risk of breast cancer from environmental chemicals, dietary agents, and endogenous steroids. The environmental factors discussed in this review include pollutants, occupational exposures, tobacco smoke, alcohol, and diet. Aromatic amines are discussed as potential mammary carcinogens, with a focus on heterocyclic amine food pyrolysis products. These compounds are excreted into the urine after consumption of meals containing cooked meats and have recently been detected in the breast milk of lactating women.

Full Text

The Full Text of this article is available as a PDF (833.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrosone C. B., Freudenheim J. L., Graham S., Marshall J. R., Vena J. E., Brasure J. R., Michalek A. M., Laughlin R., Nemoto T., Gillenwater K. A. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA. 1996 Nov 13;276(18):1494–1501. [PubMed] [Google Scholar]
  2. Ambrosone C. B., Freudenheim J. L., Sinha R., Graham S., Marshall J. R., Vena J. E., Laughlin R., Nemoto T., Shields P. G. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms. Int J Cancer. 1998 Mar 16;75(6):825–830. doi: 10.1002/(sici)1097-0215(19980316)75:6<825::aid-ijc2>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  3. Ambrosone C. B., Marshall J. R., Vena J. E., Laughlin R., Graham S., Nemoto T., Freudenheim J. L. Interaction of family history of breast cancer and dietary antioxidants with breast cancer risk (New York, United States). Cancer Causes Control. 1995 Sep;6(5):407–415. doi: 10.1007/BF00052180. [DOI] [PubMed] [Google Scholar]
  4. Aschengrau A., Coogan P. F., Quinn M., Cashins L. J. Occupational exposure to estrogenic chemicals and the occurrence of breast cancer: an exploratory analysis. Am J Ind Med. 1998 Jul;34(1):6–14. doi: 10.1002/(sici)1097-0274(199807)34:1<6::aid-ajim2>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  5. Augustsson K., Skog K., Jägerstad M., Dickman P. W., Steineck G. Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: a population-based study. Lancet. 1999 Feb 27;353(9154):703–707. doi: 10.1016/S0140-6736(98)06099-1. [DOI] [PubMed] [Google Scholar]
  6. Band P. R., Le N. D., Fang R., Deschamps M., Gallagher R. P., Yang P. Identification of occupational cancer risks in British Columbia. A population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors. J Occup Environ Med. 2000 Mar;42(3):284–310. doi: 10.1097/00043764-200003000-00010. [DOI] [PubMed] [Google Scholar]
  7. Benachenhou N., Guiral S., Gorska-Flipot I., Labuda D., Sinnett D. Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer. Br J Cancer. 1999 Mar;79(7-8):1012–1017. doi: 10.1038/sj.bjc.6690162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bernard-Gallon D. J., Dechelotte P., Rio P. G., Bignon Y. J. BRCA1 and BRCA2 proteins are expressed in milk fat globules. Int J Cancer. 1999 May 31;81(5):839–843. doi: 10.1002/(sici)1097-0215(19990531)81:5<839::aid-ijc28>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  9. Berns E. M., Foekens J. A., Vossen R., Look M. P., Devilee P., Henzen-Logmans S. C., van Staveren I. L., van Putten W. L., Inganäs M., Meijer-van Gelder M. E. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res. 2000 Apr 15;60(8):2155–2162. [PubMed] [Google Scholar]
  10. Blair A., Zahm S. H., Silverman D. T. Occupational cancer among women: research status and methodologic considerations. Am J Ind Med. 1999 Jul;36(1):6–17. doi: 10.1002/(sici)1097-0274(199907)36:1<6::aid-ajim2>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  11. Blair A., Zahm S. H., Silverman D. T. Occupational cancer among women: research status and methodologic considerations. Am J Ind Med. 1999 Jul;36(1):6–17. doi: 10.1002/(sici)1097-0274(199907)36:1<6::aid-ajim2>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  12. Blaszyk H., Hartmann A., Cunningham J. M., Schaid D., Wold L. E., Kovach J. S., Sommer S. S. A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome. Int J Cancer. 2000 Jan 20;89(1):32–38. doi: 10.1002/(sici)1097-0215(20000120)89:1<32::aid-ijc6>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  13. Buell P. Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst. 1973 Nov;51(5):1479–1483. doi: 10.1093/jnci/51.5.1479. [DOI] [PubMed] [Google Scholar]
  14. Bulbulyan M. A., Figgs L. W., Zahm S. H., Savitskaya T., Goldfarb A., Astashevsky S., Zaridze D. Cancer incidence and mortality among beta-naphthylamine and benzidine dye workers in Moscow. Int J Epidemiol. 1995 Apr;24(2):266–275. doi: 10.1093/ije/24.2.266. [DOI] [PubMed] [Google Scholar]
  15. Cavalieri E. L., Stack D. E., Devanesan P. D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S. L., Patil K. D., Gross M. L., Gooden J. K. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10937–10942. doi: 10.1073/pnas.94.20.10937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Coles C., Condie A., Chetty U., Steel C. M., Evans H. J., Prosser J. p53 mutations in breast cancer. Cancer Res. 1992 Oct 1;52(19):5291–5298. [PubMed] [Google Scholar]
  17. Crofts F. G., Strickland P. T., Hayes C. L., Sutter T. R. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human cytochrome P4501B1. Carcinogenesis. 1997 Sep;18(9):1793–1798. doi: 10.1093/carcin/18.9.1793. [DOI] [PubMed] [Google Scholar]
  18. Curran J. E., Weinstein S. R., Griffiths L. R. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Lett. 2000 May 29;153(1-2):113–120. doi: 10.1016/s0304-3835(00)00361-x. [DOI] [PubMed] [Google Scholar]
  19. Daidone M. G., Luisi A., Veneroni S., Benini E., Silvestrini R. Clinical studies of Bcl-2 and treatment benefit in breast cancer patients. Endocr Relat Cancer. 1999 Mar;6(1):61–68. doi: 10.1677/erc.0.0060061. [DOI] [PubMed] [Google Scholar]
  20. Davidson N. E. Environmental estrogens and breast cancer risk. Curr Opin Oncol. 1998 Sep;10(5):475–478. doi: 10.1097/00001622-199809000-00018. [DOI] [PubMed] [Google Scholar]
  21. Davis C. D., Ghoshal A., Schut H. A., Snyderwine E. G. Metabolism of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by lactating Fischer 344 rats and their nursing pups. J Natl Cancer Inst. 1994 Jul 20;86(14):1065–1070. doi: 10.1093/jnci/86.14.1065. [DOI] [PubMed] [Google Scholar]
  22. Davis D. L., Bradlow H. L. Can environmental estrogens cause breast cancer? Sci Am. 1995 Oct;273(4):167–172. [PubMed] [Google Scholar]
  23. Davis D. L., Bradlow H. L., Wolff M., Woodruff T., Hoel D. G., Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect. 1993 Oct;101(5):372–377. doi: 10.1289/ehp.93101372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. DeBruin L. S., Martos P. A., Josephy P. D. Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in the milk of healthy women. Chem Res Toxicol. 2001 Nov;14(11):1523–1528. doi: 10.1021/tx015556u. [DOI] [PubMed] [Google Scholar]
  25. DeBruin L. S., Pawliszyn J. B., Josephy P. D. Detection of monocyclic aromatic amines, possible mammary carcinogens, in human milk. Chem Res Toxicol. 1999 Jan;12(1):78–82. doi: 10.1021/tx980168m. [DOI] [PubMed] [Google Scholar]
  26. Deitz A. C., Zheng W., Leff M. A., Gross M., Wen W. Q., Doll M. A., Xiao G. H., Folsom A. R., Hein D. W. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):905–910. [PubMed] [Google Scholar]
  27. Delfino R. J., Sinha R., Smith C., West J., White E., Lin H. J., Liao S. Y., Gim J. S., Ma H. L., Butler J. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype. Carcinogenesis. 2000 Apr;21(4):607–615. doi: 10.1093/carcin/21.4.607. [DOI] [PubMed] [Google Scholar]
  28. Demers A., Ayotte P., Brisson J., Dodin S., Robert J., Dewailly E. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):161–166. [PubMed] [Google Scholar]
  29. Dewailly E., Dodin S., Verreault R., Ayotte P., Sauvé L., Morin J., Brisson J. High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst. 1994 Feb 2;86(3):232–234. doi: 10.1093/jnci/86.3.232. [DOI] [PubMed] [Google Scholar]
  30. Dingley K. H., Curtis K. D., Nowell S., Felton J. S., Lang N. P., Turteltaub K. W. DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):507–512. [PubMed] [Google Scholar]
  31. Dingley K. H., Freeman S. P., Nelson D. O., Garner R. C., Turteltaub K. W. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats. Drug Metab Dispos. 1998 Aug;26(8):825–828. [PubMed] [Google Scholar]
  32. Dorgan J. F., Brock J. W., Rothman N., Needham L. L., Miller R., Stephenson H. E., Jr, Schussler N., Taylor P. R. Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control. 1999 Feb;10(1):1–11. doi: 10.1023/a:1008824131727. [DOI] [PubMed] [Google Scholar]
  33. Dunning A. M., Healey C. S., Pharoah P. D., Teare M. D., Ponder B. A., Easton D. F. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):843–854. [PubMed] [Google Scholar]
  34. Egan K. M., Giovannucci E. Dietary mutagens and the risk of breast cancer. J Natl Cancer Inst. 1998 Nov 18;90(22):1687–1689. doi: 10.1093/jnci/90.22.1687. [DOI] [PubMed] [Google Scholar]
  35. Epstein S. S. Environmental and occupational pollutants are avoidable causes of breast cancer. Int J Health Serv. 1994;24(1):145–150. doi: 10.2190/5GM4-HW92-QE9K-RK37. [DOI] [PubMed] [Google Scholar]
  36. Falck F., Jr, Ricci A., Jr, Wolff M. S., Godbold J., Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health. 1992 Mar-Apr;47(2):143–146. [PubMed] [Google Scholar]
  37. Felton J. S., Knize M. G., Shen N. H., Andresen B. D., Bjeldanes L. F., Hatch F. T. Identification of the mutagens in cooked beef. Environ Health Perspect. 1986 Aug;67:17–24. doi: 10.1289/ehp.866717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Garner R. C., Lightfoot T. J., Cupid B. C., Russell D., Coxhead J. M., Kutschera W., Priller A., Rom W., Steier P., Alexander D. J. Comparative biotransformation studies of MeIQx and PhIP in animal models and humans. Cancer Lett. 1999 Sep 1;143(2):161–165. doi: 10.1016/s0304-3835(99)00118-4. [DOI] [PubMed] [Google Scholar]
  39. Gertig D. M., Hankinson S. E., Hough H., Spiegelman D., Colditz G. A., Willett W. C., Kelsey K. T., Hunter D. J. N-acetyl transferase 2 genotypes, meat intake and breast cancer risk. Int J Cancer. 1999 Jan 5;80(1):13–17. doi: 10.1002/(sici)1097-0215(19990105)80:1<13::aid-ijc3>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  40. Ghoshal A., Davis C. D., Schut H. A., Snyderwine E. G. Possible mechanisms for PhIP-DNA adduct formation in the mammary gland of female Sprague-Dawley rats. Carcinogenesis. 1995 Nov;16(11):2725–2731. doi: 10.1093/carcin/16.11.2725. [DOI] [PubMed] [Google Scholar]
  41. Glantz S. A., Parmley W. W. Passive smoking and heart disease. Mechanisms and risk. JAMA. 1995 Apr 5;273(13):1047–1053. [PubMed] [Google Scholar]
  42. Gold L. S., Slone T. H., Manley N. B., Garfinkel G. B., Hudes E. S., Rohrbach L., Ames B. N. The Carcinogenic Potency Database: analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute/National Toxicology Program. Environ Health Perspect. 1991 Dec;96:11–15. doi: 10.1289/ehp.919611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Goldberg M. S., Labrèche F. Occupational risk factors for female breast cancer: a review. Occup Environ Med. 1996 Mar;53(3):145–156. doi: 10.1136/oem.53.3.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Goth-Goldstein R., Stampfer M. R., Erdmann C. A., Russell M. Interindividual variation in CYP1A1 expression in breast tissue and the role of genetic polymorphism. Carcinogenesis. 2000 Nov;21(11):2119–2122. doi: 10.1093/carcin/21.11.2119. [DOI] [PubMed] [Google Scholar]
  45. Gross G. A., Turesky R. J., Fay L. B., Stillwell W. G., Skipper P. L., Tannenbaum S. R. Heterocyclic aromatic amine formation in grilled bacon, beef and fish and in grill scrapings. Carcinogenesis. 1993 Nov;14(11):2313–2318. doi: 10.1093/carcin/14.11.2313. [DOI] [PubMed] [Google Scholar]
  46. Guillemette C., Millikan R. C., Newman B., Housman D. E. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res. 2000 Feb 15;60(4):950–956. [PubMed] [Google Scholar]
  47. Hanna I. H., Dawling S., Roodi N., Guengerich F. P., Parl F. F. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 2000 Jul 1;60(13):3440–3444. [PubMed] [Google Scholar]
  48. Hansen J. Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Ind Med. 2000 Apr;37(4):349–352. doi: 10.1002/(sici)1097-0274(200004)37:4<349::aid-ajim4>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  49. Hartmann A., Blaszyk H., Kovach J. S., Sommer S. S. The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet. 1997 Jan;13(1):27–33. doi: 10.1016/s0168-9525(96)10043-3. [DOI] [PubMed] [Google Scholar]
  50. Hasegawa R., Kimura J., Yaono M., Takahashi S., Kato T., Futakuchi M., Fukutake M., Fukutome K., Wakabayashi K., Sugimura T. Increased risk of mammary carcinoma development following transplacental and trans-breast milk exposure to a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in Sprague-Dawley rats. Cancer Res. 1995 Oct 1;55(19):4333–4338. [PubMed] [Google Scholar]
  51. Hein D. W. N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol Lett. 2000 Mar 15;112-113:349–356. doi: 10.1016/s0378-4274(99)00226-x. [DOI] [PubMed] [Google Scholar]
  52. Helzlsouer K. J., Alberg A. J., Huang H. Y., Hoffman S. C., Strickland P. T., Brock J. W., Burse V. W., Needham L. L., Bell D. A., Lavigne J. A. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):525–532. [PubMed] [Google Scholar]
  53. Henderson B. E., Feigelson H. S. Hormonal carcinogenesis. Carcinogenesis. 2000 Mar;21(3):427–433. doi: 10.1093/carcin/21.3.427. [DOI] [PubMed] [Google Scholar]
  54. Huang C. S., Shen C. Y., Chang K. J., Hsu S. M., Chern H. D. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Br J Cancer. 1999 Aug;80(11):1838–1843. doi: 10.1038/sj.bjc.6690608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Hung M. C., Lau Y. K. Basic science of HER-2/neu: a review. Semin Oncol. 1999 Aug;26(4 Suppl 12):51–59. [PubMed] [Google Scholar]
  56. Hunter D. J., Hankinson S. E., Hough H., Gertig D. M., Garcia-Closas M., Spiegelman D., Manson J. E., Colditz G. A., Willett W. C., Speizer F. E. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis. 1997 Nov;18(11):2127–2132. doi: 10.1093/carcin/18.11.2127. [DOI] [PubMed] [Google Scholar]
  57. Hunter D. J., Hankinson S. E., Laden F., Colditz G. A., Manson J. E., Willett W. C., Speizer F. E., Wolff M. S. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med. 1997 Oct 30;337(18):1253–1258. doi: 10.1056/NEJM199710303371801. [DOI] [PubMed] [Google Scholar]
  58. Hussain S. P., Hollstein M. H., Harris C. C. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment. Ann N Y Acad Sci. 2000;919:79–85. doi: 10.1111/j.1749-6632.2000.tb06870.x. [DOI] [PubMed] [Google Scholar]
  59. Imaida K., Hagiwara A., Yada H., Masui T., Hasegawa R., Hirose M., Sugimura T., Ito N., Shirai T. Dose-dependent induction of mammary carcinomas in female Sprague-Dawley rats with 2-amino-1-methyl-6-phenylimidazol[4,5-b]pyridine. Jpn J Cancer Res. 1996 Nov;87(11):1116–1120. doi: 10.1111/j.1349-7006.1996.tb03120.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Ishibe N., Hankinson S. E., Colditz G. A., Spiegelman D., Willett W. C., Speizer F. E., Kelsey K. T., Hunter D. J. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res. 1998 Feb 15;58(4):667–671. [PubMed] [Google Scholar]
  61. Ito N., Hasegawa R., Imaida K., Tamano S., Hagiwara A., Hirose M., Shirai T. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat Res. 1997 May 12;376(1-2):107–114. doi: 10.1016/s0027-5107(97)00032-8. [DOI] [PubMed] [Google Scholar]
  62. Ito N., Hasegawa R., Sano M., Tamano S., Esumi H., Takayama S., Sugimura T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 1991 Aug;12(8):1503–1506. doi: 10.1093/carcin/12.8.1503. [DOI] [PubMed] [Google Scholar]
  63. Johnson K. C., Hu J., Mao Y., Canadian Cancer Registries Epidemiology Research Group Passive and active smoking and breast cancer risk in Canada, 1994-97. Cancer Causes Control. 2000 Mar;11(3):211–221. doi: 10.1023/a:1008906105790. [DOI] [PubMed] [Google Scholar]
  64. Jägerstad I. M., Johansson M. A., Karlsson A. A., Skog K. I., Oskarsson A., Palminger-Hallén I., Ivhed R., Brittebo E. B. Dose-dependent milk transfer and tissue distribution of the food mutagen PhIP in rats and their suckling pups. Carcinogenesis. 1994 Nov;15(11):2479–2484. doi: 10.1093/carcin/15.11.2479. [DOI] [PubMed] [Google Scholar]
  65. Kataoka H., Hayatsu T., Hietsch G., Steinkellner H., Nishioka S., Narimatsu S., Knasmüller S., Hayatsu H. Identification of mutagenic heterocyclic amines (IQ, Trp-P-1 and AalphaC) in the water of the Danube river. Mutat Res. 2000 Mar 3;466(1):27–35. doi: 10.1016/s1383-5718(99)00235-1. [DOI] [PubMed] [Google Scholar]
  66. Kataoka H., Kijima K., Maruo G. Determination of mutagenic heterocyclic amines in combustion smoke samples. Bull Environ Contam Toxicol. 1998 Jan;60(1):60–67. doi: 10.1007/s001289900591. [DOI] [PubMed] [Google Scholar]
  67. Kataoka H. Methods for the determination of mutagenic heterocyclic amines and their applications in environmental analysis. J Chromatogr A. 1997 Jul 11;774(1-2):121–142. doi: 10.1016/s0021-9673(97)00246-x. [DOI] [PubMed] [Google Scholar]
  68. Katsama A., Sourvinos G., Zachos G., Spandidos D. A. Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma. Cancer Lett. 2000 Mar 31;150(2):165–170. doi: 10.1016/s0304-3835(99)00386-9. [DOI] [PubMed] [Google Scholar]
  69. Kelsey J. L., Horn-Ross P. L. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev. 1993;15(1):7–16. doi: 10.1093/oxfordjournals.epirev.a036118. [DOI] [PubMed] [Google Scholar]
  70. Knize M. G., Salmon C. P., Mehta S. S., Felton J. S. Analysis of cooked muscle meats for heterocyclic aromatic amine carcinogens. Mutat Res. 1997 May 12;376(1-2):129–134. doi: 10.1016/s0027-5107(97)00035-3. [DOI] [PubMed] [Google Scholar]
  71. Knize M. G., Salmon C. P., Pais P., Felton J. S. Food heating and the formation of heterocyclic aromatic amine and polycyclic aromatic hydrocarbon mutagens/carcinogens. Adv Exp Med Biol. 1999;459:179–193. doi: 10.1007/978-1-4615-4853-9_12. [DOI] [PubMed] [Google Scholar]
  72. Krieger N., Wolff M. S., Hiatt R. A., Rivera M., Vogelman J., Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst. 1994 Apr 20;86(8):589–599. doi: 10.1093/jnci/86.8.589. [DOI] [PubMed] [Google Scholar]
  73. Kulldorff M., Feuer E. J., Miller B. A., Freedman L. S. Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol. 1997 Jul 15;146(2):161–170. doi: 10.1093/oxfordjournals.aje.a009247. [DOI] [PubMed] [Google Scholar]
  74. Kulp K. S., Knize M. G., Malfatti M. A., Salmon C. P., Felton J. S. Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans. Carcinogenesis. 2000 Nov;21(11):2065–2072. doi: 10.1093/carcin/21.11.2065. [DOI] [PubMed] [Google Scholar]
  75. Labrèche F. P., Goldberg M. S. Exposure to organic solvents and breast cancer in women: a hypothesis. Am J Ind Med. 1997 Jul;32(1):1–14. doi: 10.1002/(sici)1097-0274(199707)32:1<1::aid-ajim1>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  76. Laden F., Collman G., Iwamoto K., Alberg A. J., Berkowitz G. S., Freudenheim J. L., Hankinson S. E., Helzlsouer K. J., Holford T. R., Huang H. Y. 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst. 2001 May 16;93(10):768–776. doi: 10.1093/jnci/93.10.768. [DOI] [PubMed] [Google Scholar]
  77. Laden F., Hankinson S. E., Wolff M. S., Colditz G. A., Willett W. C., Speizer F. E., Hunter D. J. Plasma organochlorine levels and the risk of breast cancer: an extended follow-up in the Nurses' Health Study. Int J Cancer. 2001 Feb 15;91(4):568–574. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1081>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  78. Langouët S., Welti D. H., Kerriguy N., Fay L. B., Huynh-Ba T., Markovic J., Guengerich F. P., Guillouzo A., Turesky R. J. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2. Chem Res Toxicol. 2001 Feb;14(2):211–221. doi: 10.1021/tx000176e. [DOI] [PubMed] [Google Scholar]
  79. Layton D. W., Bogen K. T., Knize M. G., Hatch F. T., Johnson V. M., Felton J. S. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis. 1995 Jan;16(1):39–52. doi: 10.1093/carcin/16.1.39. [DOI] [PubMed] [Google Scholar]
  80. Layton D. W., Bogen K. T., Knize M. G., Hatch F. T., Johnson V. M., Felton J. S. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis. 1995 Jan;16(1):39–52. doi: 10.1093/carcin/16.1.39. [DOI] [PubMed] [Google Scholar]
  81. Lewis-Michl E. L., Melius J. M., Kallenbach L. R., Ju C. L., Talbot T. O., Orr M. F., Lauridsen P. E. Breast cancer risk and residence near industry or traffic in Nassau and Suffolk Counties, Long Island, New York. Arch Environ Health. 1996 Jul-Aug;51(4):255–265. doi: 10.1080/00039896.1996.9936024. [DOI] [PubMed] [Google Scholar]
  82. Lewis A. J., Walle U. K., King R. S., Kadlubar F. F., Falany C. N., Walle T. Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells. Carcinogenesis. 1998 Nov;19(11):2049–2053. doi: 10.1093/carcin/19.11.2049. [DOI] [PubMed] [Google Scholar]
  83. Li D., Wang M., Dhingra K., Hittelman W. N. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res. 1996 Jan 15;56(2):287–293. [PubMed] [Google Scholar]
  84. Lichtenstein P., Holm N. V., Verkasalo P. K., Iliadou A., Kaprio J., Koskenvuo M., Pukkala E., Skytthe A., Hemminki K. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000 Jul 13;343(2):78–85. doi: 10.1056/NEJM200007133430201. [DOI] [PubMed] [Google Scholar]
  85. Lightfoot T. J., Coxhead J. M., Cupid B. C., Nicholson S., Garner R. C. Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyrene. Mutat Res. 2000 Dec 20;472(1-2):119–127. doi: 10.1016/s1383-5718(00)00134-0. [DOI] [PubMed] [Google Scholar]
  86. Longnecker M. P. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control. 1994 Jan;5(1):73–82. doi: 10.1007/BF01830729. [DOI] [PubMed] [Google Scholar]
  87. Magagnotti C., Orsi F., Bagnati R., Celli N., Rotilio D., Fanelli R., Airoldi L. Effect of diet on serum albumin and hemoglobin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans. Int J Cancer. 2000 Oct 1;88(1):1–6. doi: 10.1002/1097-0215(20001001)88:1<1::aid-ijc1>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  88. Malfatti M. A., Kulp K. S., Knize M. G., Davis C., Massengill J. P., Williams S., Nowell S., MacLeod S., Dingley K. H., Turteltaub K. W. The identification of [2-(14)C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans. Carcinogenesis. 1999 Apr;20(4):705–713. doi: 10.1093/carcin/20.4.705. [DOI] [PubMed] [Google Scholar]
  89. Martin F. L., Cole K. J., Weaver G., Williams J. A., Millar B. C., Grover P. L., Phillips D. H. Genotoxicity of human milk extracts and detection of DNA damage in exfoliated cells recovered from breast milk. Biochem Biophys Res Commun. 1999 Jun 7;259(2):319–326. [PubMed] [Google Scholar]
  90. Martin F. L., Cole K. J., Williams J. A., Millar B. C., Harvey D., Weaver G., Grover P. L., Phillips D. H. Activation of genotoxins to DNA-damaging species in exfoliated breast milk cells. Mutat Res. 2000 Oct 31;470(2):115–124. doi: 10.1016/s1383-5742(00)00046-6. [DOI] [PubMed] [Google Scholar]
  91. Matos E. L., Thomas D. B., Sobel N., Vuoto D. Breast cancer in Argentina: case-control study with special reference to meat eating habits. Neoplasma. 1991;38(3):357–366. [PubMed] [Google Scholar]
  92. Matsui A., Ikeda T., Enomoto K., Nakashima H., Omae K., Watanabe M., Hibi T., Kitajima M. Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase. Cancer Lett. 2000 Mar 13;150(1):23–31. doi: 10.1016/s0304-3835(99)00368-7. [DOI] [PubMed] [Google Scholar]
  93. Mauthe R. J., Snyderwine E. G., Ghoshal A., Freeman S. P., Turteltaub K. W. Distribution and metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in female rats and their pups at dietary doses. Carcinogenesis. 1998 May;19(5):919–924. doi: 10.1093/carcin/19.5.919. [DOI] [PubMed] [Google Scholar]
  94. Millikan R. C., Pittman G. S., Newman B., Tse C. K., Selmin O., Rockhill B., Savitz D., Moorman P. G., Bell D. A. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):371–378. [PubMed] [Google Scholar]
  95. Morabia A., Bernstein M. S., Bouchardy I., Kurtz J., Morris M. A. Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype. Am J Epidemiol. 2000 Aug 1;152(3):226–232. doi: 10.1093/aje/152.3.226. [DOI] [PubMed] [Google Scholar]
  96. Morabia A., Bernstein M., Héritier S., Khatchatrian N. Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol. 1996 May 1;143(9):918–928. doi: 10.1093/oxfordjournals.aje.a008835. [DOI] [PubMed] [Google Scholar]
  97. Morris J. J., Seifter E. The role of aromatic hydrocarbons in the genesis of breast cancer. Med Hypotheses. 1992 Jul;38(3):177–184. doi: 10.1016/0306-9877(92)90090-y. [DOI] [PubMed] [Google Scholar]
  98. Morton W. E. Major differences in breast cancer risks among occupations. J Occup Environ Med. 1995 Mar;37(3):328–335. doi: 10.1097/00043764-199503000-00010. [DOI] [PubMed] [Google Scholar]
  99. Murray S., Gooderham N. J., Boobis A. R., Davies D. S. Detection and measurement of MeIQx in human urine after ingestion of a cooked meat meal. Carcinogenesis. 1989 Apr;10(4):763–765. doi: 10.1093/carcin/10.4.763. [DOI] [PubMed] [Google Scholar]
  100. Männistö S., Virtanen M., Kataja V., Uusitupa M., Pietinen P. Lifetime alcohol consumption and breast cancer: a case-control study in Finland. Public Health Nutr. 2000 Mar;3(1):11–18. doi: 10.1017/s1368980000000033. [DOI] [PubMed] [Google Scholar]
  101. Ménard S., Tagliabue E., Campiglio M., Pupa S. M. Role of HER2 gene overexpression in breast carcinoma. J Cell Physiol. 2000 Feb;182(2):150–162. doi: 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  102. Nagao M., Ushijima T., Wakabayashi K., Ochiai M., Kushida H., Sugimura T., Hasegawa R., Shirai T., Ito N. Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods. Cancer. 1994 Aug 1;74(3 Suppl):1063–1069. doi: 10.1002/1097-0142(19940801)74:3+<1063::aid-cncr2820741514>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  103. Nowell S. A., Massengill J. S., Williams S., Radominska-Pandya A., Tephly T. R., Cheng Z., Strassburg C. P., Tukey R. H., MacLeod S. L., Lang N. P. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. Carcinogenesis. 1999 Jun;20(6):1107–1114. doi: 10.1093/carcin/20.6.1107. [DOI] [PubMed] [Google Scholar]
  104. Park S. K., Yoo K. Y., Lee S. J., Kim S. U., Ahn S. H., Noh D. Y., Choe K. J., Strickland P. T., Hirvonen A., Kang D. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics. 2000 Jun;10(4):301–309. doi: 10.1097/00008571-200006000-00004. [DOI] [PubMed] [Google Scholar]
  105. Perera F. P., Estabrook A., Hewer A., Channing K., Rundle A., Mooney L. A., Whyatt R., Phillips D. H. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev. 1995 Apr-May;4(3):233–238. [PubMed] [Google Scholar]
  106. Popp W., Schmieding W., Speck M., Vahrenholz C., Norpoth K. Incidence of bladder cancer in a cohort of workers exposed to 4-chloro-o-toluidine while synthesising chlordimeform. Br J Ind Med. 1992 Aug;49(8):529–531. doi: 10.1136/oem.49.8.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Reistad R., Rossland O. J., Latva-Kala K. J., Rasmussen T., Vikse R., Becher G., Alexander J. Heterocyclic aromatic amines in human urine following a fried meat meal. Food Chem Toxicol. 1997 Oct-Nov;35(10-11):945–955. doi: 10.1016/s0278-6915(97)00112-9. [DOI] [PubMed] [Google Scholar]
  108. Rohan T. E., Jain M., Howe G. R., Miller A. B. Alcohol consumption and risk of breast cancer: a cohort study. Cancer Causes Control. 2000 Mar;11(3):239–247. doi: 10.1023/a:1008933824645. [DOI] [PubMed] [Google Scholar]
  109. Ronco A., De Stefani E., Mendilaharsu M., Deneo-Pellegrini H. Meat, fat and risk of breast cancer: a case-control study from Uruguay. Int J Cancer. 1996 Jan 26;65(3):328–331. doi: 10.1002/(SICI)1097-0215(19960126)65:3<328::AID-IJC9>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  110. Rundle A., Tang D., Hibshoosh H., Estabrook A., Schnabel F., Cao W., Grumet S., Perera F. P. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis. 2000 Jul;21(7):1281–1289. [PubMed] [Google Scholar]
  111. Russo I. H., Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 1996 Sep;104(9):938–967. doi: 10.1289/ehp.96104938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Russo J., Russo I. H. The pathway of neoplastic transformation of human breast epithelial cells. Radiat Res. 2001 Jan;155(1 Pt 2):151–154. doi: 10.1667/0033-7587(2001)155[0151:tponto]2.0.co;2. [DOI] [PubMed] [Google Scholar]
  113. Safe S. H. Endocrine disruptors and human health--is there a problem? An update. Environ Health Perspect. 2000 Jun;108(6):487–493. doi: 10.1289/ehp.00108487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Safe S. H. Is there an association between exposure to environmental estrogens and breast cancer? Environ Health Perspect. 1997 Apr;105 (Suppl 3):675–678. doi: 10.1289/ehp.97105s3675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Safe S. H., Zacharewski T. Organochlorine exposure and risk for breast cancer. Prog Clin Biol Res. 1997;396:133–145. [PubMed] [Google Scholar]
  116. Salmon C. P., Knize M. G., Felton J. S. Effects of marinating on heterocyclic amine carcinogen formation in grilled chicken. Food Chem Toxicol. 1997 May;35(5):433–441. doi: 10.1016/s0278-6915(97)00020-3. [DOI] [PubMed] [Google Scholar]
  117. Schatzkin A., Longnecker M. P. Alcohol and breast cancer. Where are we now and where do we go from here? Cancer. 1994 Aug 1;74(3 Suppl):1101–1110. doi: 10.1002/1097-0142(19940801)74:3+<1101::aid-cncr2820741519>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  118. Schecter A., Toniolo P., Dai L. C., Thuy L. T., Wolff M. S. Blood levels of DDT and breast cancer risk among women living in the north of Vietnam. Arch Environ Contam Toxicol. 1997 Nov;33(4):453–456. doi: 10.1007/s002449900276. [DOI] [PubMed] [Google Scholar]
  119. Schorr K., Li M., Krajewski S., Reed J. C., Furth P. A. Bcl-2 gene family and related proteins in mammary gland involution and breast cancer. J Mammary Gland Biol Neoplasia. 1999 Apr;4(2):153–164. doi: 10.1023/a:1018773123899. [DOI] [PubMed] [Google Scholar]
  120. Schut H. A., Yao R. Tea as a potential chemopreventive agent in PhIP carcinogenesis: effects of green tea and black tea on PhIP-DNA adduct formation in female F-344 rats. Nutr Cancer. 2000;36(1):52–58. doi: 10.1207/S15327914NC3601_8. [DOI] [PubMed] [Google Scholar]
  121. Segasothy M., Phillips P. A. Vegetarian diet: panacea for modern lifestyle diseases? QJM. 1999 Sep;92(9):531–544. doi: 10.1093/qjmed/92.9.531. [DOI] [PubMed] [Google Scholar]
  122. Sellers T. A., Kushi L. H., Cerhan J. R., Vierkant R. A., Gapstur S. M., Vachon C. M., Olson J. E., Therneau T. M., Folsom A. R. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology. 2001 Jul;12(4):420–428. doi: 10.1097/00001648-200107000-00012. [DOI] [PubMed] [Google Scholar]
  123. Shrubsole M. J., Jin F., Dai Q., Shu X. O., Potter J. D., Hebert J. R., Gao Y. T., Zheng W. Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Res. 2001 Oct 1;61(19):7136–7141. [PubMed] [Google Scholar]
  124. Sinha R., Gustafson D. R., Kulldorff M., Wen W. Q., Cerhan J. R., Zheng W. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. J Natl Cancer Inst. 2000 Aug 16;92(16):1352–1354. doi: 10.1093/jnci/92.16.1352. [DOI] [PubMed] [Google Scholar]
  125. Smith-Warner S. A., Spiegelman D., Yaun S. S., Adami H. O., Beeson W. L., van den Brandt P. A., Folsom A. R., Fraser G. E., Freudenheim J. L., Goldbohm R. A. Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA. 2001 Feb 14;285(6):769–776. doi: 10.1001/jama.285.6.769. [DOI] [PubMed] [Google Scholar]
  126. Smith-Warner S. A., Spiegelman D., Yaun S. S., van den Brandt P. A., Folsom A. R., Goldbohm R. A., Graham S., Holmberg L., Howe G. R., Marshall J. R. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998 Feb 18;279(7):535–540. doi: 10.1001/jama.279.7.535. [DOI] [PubMed] [Google Scholar]
  127. Snedeker S. M. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ Health Perspect. 2001 Mar;109 (Suppl 1):35–47. doi: 10.1289/ehp.01109s135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Snyderwine E. G. Diet and mammary gland carcinogenesis. Recent Results Cancer Res. 1998;152:3–10. doi: 10.1007/978-3-642-45769-2_1. [DOI] [PubMed] [Google Scholar]
  129. Snyderwine E. G. Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats: possible mechanisms. Cancer Lett. 1999 Sep 1;143(2):211–215. doi: 10.1016/s0304-3835(99)00127-5. [DOI] [PubMed] [Google Scholar]
  130. Snyderwine E. G., Thorgeirsson U. P., Venugopal M., Roberts-Thomson S. J. Mammary gland carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Sprague-Dawley rats on high- and low-fat diets. Nutr Cancer. 1998;31(3):160–167. doi: 10.1080/01635589809514698. [DOI] [PubMed] [Google Scholar]
  131. Sonnenschein C., Soto A. M. An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):143–150. doi: 10.1016/s0960-0760(98)00027-2. [DOI] [PubMed] [Google Scholar]
  132. Soto A. M., Sonnenschein C., Chung K. L., Fernandez M. F., Olea N., Serrano F. O. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect. 1995 Oct;103 (Suppl 7):113–122. doi: 10.1289/ehp.95103s7113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Thiébaud H. P., Knize M. G., Kuzmicky P. A., Hsieh D. P., Felton J. S. Airborne mutagens produced by frying beef, pork and a soy-based food. Food Chem Toxicol. 1995 Oct;33(10):821–828. doi: 10.1016/0278-6915(95)00057-9. [DOI] [PubMed] [Google Scholar]
  134. Thompson P. A., Shields P. G., Freudenheim J. L., Stone A., Vena J. E., Marshall J. R., Graham S., Laughlin R., Nemoto T., Kadlubar F. F. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res. 1998 May 15;58(10):2107–2110. [PubMed] [Google Scholar]
  135. Thomson B. Heterocyclic amine levels in cooked meat and the implication for New Zealanders. Eur J Cancer Prev. 1999 Jul;8(3):201–206. doi: 10.1097/00008469-199906000-00007. [DOI] [PubMed] [Google Scholar]
  136. Tominaga S., Kuroishi T. Epidemiology of breast cancer in Japan. Cancer Lett. 1995 Mar 23;90(1):75–79. doi: 10.1016/0304-3835(94)03680-h. [DOI] [PubMed] [Google Scholar]
  137. Toniolo P., Riboli E., Shore R. E., Pasternack B. S. Consumption of meat, animal products, protein, and fat and risk of breast cancer: a prospective cohort study in New York. Epidemiology. 1994 Jul;5(4):391–397. doi: 10.1097/00001648-199407000-00003. [DOI] [PubMed] [Google Scholar]
  138. Turesky R. J., Gremaud E., Markovic J., Snyderwine E. G. DNA adduct formation of the food-derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay. Chem Res Toxicol. 1996 Mar;9(2):403–408. doi: 10.1021/tx950132j. [DOI] [PubMed] [Google Scholar]
  139. Turesky R. J., Rossi S. C., Welti D. H., Lay J. O., Jr, Kadlubar F. F. Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine. Chem Res Toxicol. 1992 Jul-Aug;5(4):479–490. doi: 10.1021/tx00028a005. [DOI] [PubMed] [Google Scholar]
  140. Ushiyama H., Wakabayashi K., Hirose M., Itoh H., Sugimura T., Nagao M. Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. Carcinogenesis. 1991 Aug;12(8):1417–1422. doi: 10.1093/carcin/12.8.1417. [DOI] [PubMed] [Google Scholar]
  141. Vatten L. J., Solvoll K., Løken E. B. Frequency of meat and fish intake and risk of breast cancer in a prospective study of 14,500 Norwegian women. Int J Cancer. 1990 Jul 15;46(1):12–15. doi: 10.1002/ijc.2910460105. [DOI] [PubMed] [Google Scholar]
  142. Wakabayashi K., Ushiyama H., Takahashi M., Nukaya H., Kim S. B., Hirose M., Ochiai M., Sugimura T., Nagao M. Exposure to heterocyclic amines. Environ Health Perspect. 1993 Mar;99:129–134. doi: 10.1289/ehp.9399129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Wang H., Zeng Z. C., Bui T. A., DiBiase S. J., Qin W., Xia F., Powell S. N., Iliakis G. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. Cancer Res. 2001 Jan 1;61(1):270–277. [PubMed] [Google Scholar]
  144. Ward E. M., Sabbioni G., DeBord D. G., Teass A. W., Brown K. K., Talaska G. G., Roberts D. R., Ruder A. M., Streicher R. P. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess. J Natl Cancer Inst. 1996 Aug 7;88(15):1046–1052. doi: 10.1093/jnci/88.15.1046. [DOI] [PubMed] [Google Scholar]
  145. Watanabe J., Shimada T., Gillam E. M., Ikuta T., Suemasu K., Higashi Y., Gotoh O., Kawajiri K. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics. 2000 Feb;10(1):25–33. doi: 10.1097/00008571-200002000-00004. [DOI] [PubMed] [Google Scholar]
  146. Widersten M., Pearson W. R., Engström A., Mannervik B. Heterologous expression of the allelic variant mu-class glutathione transferases mu and psi. Biochem J. 1991 Jun 1;276(Pt 2):519–524. doi: 10.1042/bj2760519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Willett W. C. Dietary fat and breast cancer. Toxicol Sci. 1999 Dec;52(2 Suppl):127–146. doi: 10.1093/toxsci/52.2.127. [DOI] [PubMed] [Google Scholar]
  148. Williams J. A., Stone E. M., Millar B. C., Hewer A., Phillips D. H. Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts. Mutagenesis. 2000 Mar;15(2):149–154. doi: 10.1093/mutage/15.2.149. [DOI] [PubMed] [Google Scholar]
  149. Wolff M. S., Collman G. W., Barrett J. C., Huff J. Breast cancer and environmental risk factors: epidemiological and experimental findings. Annu Rev Pharmacol Toxicol. 1996;36:573–596. doi: 10.1146/annurev.pa.36.040196.003041. [DOI] [PubMed] [Google Scholar]
  150. Wolff M. S. Half-lives of organochlorines (OCs) in humans. Arch Environ Contam Toxicol. 1999 May;36(4):504–504. doi: 10.1007/pl00006624. [DOI] [PubMed] [Google Scholar]
  151. Wolff M. S., Toniolo P. G., Lee E. W., Rivera M., Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst. 1993 Apr 21;85(8):648–652. doi: 10.1093/jnci/85.8.648. [DOI] [PubMed] [Google Scholar]
  152. Wolff M. S., Zeleniuch-Jacquotte A., Dubin N., Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):271–277. [PubMed] [Google Scholar]
  153. Yang C. C., Jenq S. N., Lee H. Characterization of the carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in cooking aerosols under domestic conditions. Carcinogenesis. 1998 Feb;19(2):359–363. doi: 10.1093/carcin/19.2.359. [DOI] [PubMed] [Google Scholar]
  154. Yang H. H., Li X. C., Amft M., Grotemeyer J. Protein conformational changes determined by matrix-assisted laser desorption mass spectrometry. Anal Biochem. 1998 Apr 10;258(1):118–126. doi: 10.1006/abio.1997.2549. [DOI] [PubMed] [Google Scholar]
  155. Yang X., Lippman M. E. BRCA1 and BRCA2 in breast cancer. Breast Cancer Res Treat. 1999 Mar;54(1):1–10. doi: 10.1023/a:1006189906896. [DOI] [PubMed] [Google Scholar]
  156. Yu H. Alcohol consumption and breast cancer risk. JAMA. 1998 Oct 7;280(13):1138–1139. doi: 10.1001/jama.280.13.1138-a. [DOI] [PubMed] [Google Scholar]
  157. Yu H., Berkel J. Do insulin-like growth factors mediate the effect of alcohol on breast cancer risk? Med Hypotheses. 1999 Jun;52(6):491–496. doi: 10.1054/mehy.1998.0828. [DOI] [PubMed] [Google Scholar]
  158. Zahm S. H., Pottern L. M., Lewis D. R., Ward M. H., White D. W. Inclusion of women and minorities in occupational cancer epidemiologic research. J Occup Med. 1994 Aug;36(8):842–847. [PubMed] [Google Scholar]
  159. Zhang S., Hunter D. J., Forman M. R., Rosner B. A., Speizer F. E., Colditz G. A., Manson J. E., Hankinson S. E., Willett W. C. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst. 1999 Mar 17;91(6):547–556. doi: 10.1093/jnci/91.6.547. [DOI] [PubMed] [Google Scholar]
  160. Zhang S., Hunter D. J., Hankinson S. E., Giovannucci E. L., Rosner B. A., Colditz G. A., Speizer F. E., Willett W. C. A prospective study of folate intake and the risk of breast cancer. JAMA. 1999 May 5;281(17):1632–1637. doi: 10.1001/jama.281.17.1632. [DOI] [PubMed] [Google Scholar]
  161. Zheng T., Holford T. R., Mayne S. T., Ward B., Carter D., Owens P. H., Dubrow R., Zahm S. H., Boyle P., Archibeque S. DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol. 1999 Sep 1;150(5):453–458. doi: 10.1093/oxfordjournals.aje.a010033. [DOI] [PubMed] [Google Scholar]
  162. Zheng W., Deitz A. C., Campbell D. R., Wen W. Q., Cerhan J. R., Sellers T. A., Folsom A. R., Hein D. W. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999 Mar;8(3):233–239. [PubMed] [Google Scholar]
  163. Zheng W., Gustafson D. R., Sinha R., Cerhan J. R., Moore D., Hong C. P., Anderson K. E., Kushi L. H., Sellers T. A., Folsom A. R. Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst. 1998 Nov 18;90(22):1724–1729. doi: 10.1093/jnci/90.22.1724. [DOI] [PubMed] [Google Scholar]
  164. Zheng W., Xie D. W., Jin F., Cheng J. R., Dai Q., Wen W. Q., Shu X. O., Gao Y. T. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):147–150. [PubMed] [Google Scholar]
  165. Zheng W., Xie D., Cerhan J. R., Sellers T. A., Wen W., Folsom A. R. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):89–94. [PubMed] [Google Scholar]
  166. el-Bayoumy K. Environmental carcinogens that may be involved in human breast cancer etiology. Chem Res Toxicol. 1992 Sep-Oct;5(5):585–590. doi: 10.1021/tx00029a001. [DOI] [PubMed] [Google Scholar]
  167. van't Veer P., Lobbezoo I. E., Martín-Moreno J. M., Guallar E., Gómez-Aracena J., Kardinaal A. F., Kohlmeier L., Martin B. C., Strain J. J., Thamm M. DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study. BMJ. 1997 Jul 12;315(7100):81–85. doi: 10.1136/bmj.315.7100.81. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES